Romagnoli, Romeo and Baraldi, Pier Giovanni and Carrion, Maria Dora and Cruz-Lopez, Olga and Preti, Delia and Tabrizi, Mojgan Aghazadeh and Fruttarolo, Francesca and Heilmann, Jörg and Bermejo, Jaime and Estevez, Francisco (2007) Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha -bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukemia cells. Bioorganic & medicinal chemistry letters 17 (10), pp. 2844-2848.
Full text not available from this repository.
Abstract
The synthesis and biol. activity of a series of hybrids I (n = 3, 6; X = NH, NMe, O, S) prepd. combining a benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and different benzoheterocyclic alpha -bromoacryloyl amides have been described and their structure-activity relationships discussed. All these hetero-bifunctional compds. were highly cytotoxic against the human myeloid leukemia cell lines HL-60 and U937 (IC50 0.24-1.72 micro M), significantly superior to that of both alkylating units alone. In human myeloid leukemia HL-60 cells we obsd. that these compds. suppress survival and proliferation by triggering morphol. changes and internucleosomal DNA fragmentation characteristic of apoptotic cell death. The apoptosis induced by these compds. is mediated by caspase-3 activation and is also assocd. to an early release of cytochrome c from the mitochondria.
| Item Type: | Article | ||||
|---|---|---|---|---|---|
| Additional information (public): | CAN 147:95597 28-9 Heterocyclic Compounds (More Than One Hetero Atom) 942267-96-1P; 942267-97-2P; 942267-98-3P; 942267-99-4P; 942268-00-0P Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (prepn. of hybrid mols. contg. benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha -bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukemia cells); 109-76-2 (1,3-Diaminopropane); 124-09-4 (1,6-Diaminohexane); 196196-26-6; 207845-97-4; 245358-71-8; 294174-53-1; 561318-70-5 Role: RCT (Reactant), RACT (Reactant or reagent) (prepn. of hybrid mols. contg. benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha -bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukemia cells); 942268-01-1P; 942268-02-2P Role: RCT (Reactant), SPN (Synthetic preparation), PREP (Preparation), RACT (Reactant or reagent) (prepn. of hybrid mols. contg. benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha -bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukemia cells) | ||||
| Institutions: | Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical Biology (Prof. Heilmann) | ||||
| Identification Number: |
| ||||
| Keywords: | Structure-activity relationship (antitumor prepn. of hybrid mols. contg. benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha -bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukemia cells) Antitumor agents Apoptosis Human Leukemia (prepn. of hybrid mols. contg. benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha -bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukemia cells) benzoimidazothiadiazole bromoacryloyl prepn apoptosis inducer myeloid leukemia | ||||
| Subjects: | 500 Science > 570 Life sciences 500 Science > 540 Chemistry & allied sciences | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Owner: | Prof. Dr. Joerg Heilmann | ||||
| Deposited On: | 18 Oct 2010 15:23 | ||||
| Last Modified: | 18 Oct 2010 15:23 | ||||
| Item ID: | 17234 |
- ASCII Citation
- BibTeX
- Dublin Core
- EndNote
- HTML Citation
- METS
- OAI-ORE Resource Map (Atom Format)
- OAI-ORE Resource Map (RDF Format)
- RDF+N-Triples
- RDF+N3
- RDF+XML
- Refer
- Reference Manager
- Simple Metadata
- XML
- xMetaDissPlus
Literature of the same author
Bookmark
Deutsch
in this repository
Citeulike
Connotea
Del.icio.us
Digg
Facebook